Literature DB >> 28726034

Mentally stimulating activities associate with better cognitive performance in Parkinson disease.

Jeffrey L B Bohnen1, Martijn L T M Müller1,2, Jacob Haugen1, Nicolaas I Bohnen3,4,5,6.   

Abstract

Subjects at risk of dementia benefit from participation in mentally stimulating activities, but no prior studies have investigated similar associations in Parkinson disease (PD). The aim of this study was to investigate the relationship between times spent engaging in mentally stimulating activities and cognitive functions in PD while accounting for the degree of primary neurodegenerations. PD patients (N = 41, 33 males; age 68.5 ± 7.2; Hoehn and Yahr stage 2.6 ± 0.6) completed the Community Health Activities Model Program for Seniors questionnaire, mini-mental state examination (MMSE), and [11C]dihydrotetrabenazine dopaminergic and [11C]piperidinyl propionate acetylcholinesterase PET imaging. The subset of mentally stimulating activity items of the Community Health Activities Model Program for Seniors questionnaire was used to develop a rating scale as primary outcome variable in this study. Findings showed that mean rating scale score of time spent in mentally stimulating activities over a 4-week timespan was 20.0 ± 8.3 h and mean MMSE score was 28.4 ± 1.9. Regression analysis showed that duration of participation in mentally stimulating activities was a significant predictor of MMSE scores (standardized β = 0.39, t = 2.8, p = 0.009; total model: F (6,34) = 3.5, p = 0.005) independent from significant effects for cortical cholinergic activity (β = 0.35, t = 2.4, p = 0.024). Caudate nucleus dopaminergic activity, age, education, or duration of disease were not significant regressors. Post hoc analysis did not show significant effects of motor disease severity or level of physical activities. We conclude that engagement in mentally stimulating activities is associated with better cognitive abilities in PD, independent of education, severity of motor disease, nigrostriatal dopaminergic and cortical cholinergic degenerations.

Entities:  

Keywords:  Acetylcholine; Cognition; Cognitive stimulation; Dopamine; PET; Parkinson disease

Mesh:

Substances:

Year:  2017        PMID: 28726034      PMCID: PMC5693756          DOI: 10.1007/s00702-017-1761-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.

Authors:  J Verghese; A LeValley; C Derby; G Kuslansky; M Katz; C Hall; H Buschke; R B Lipton
Journal:  Neurology       Date:  2006-02-08       Impact factor: 9.910

2.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain.

Authors:  N R Selden; D R Gitelman; N Salamon-Murayama; T B Parrish; M M Mesulam
Journal:  Brain       Date:  1998-12       Impact factor: 13.501

3.  Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study.

Authors:  Yonas E Geda; Hillary M Topazian; Lewis A Roberts; Robert A Lewis; Rosebud O Roberts; David S Knopman; V Shane Pankratz; Teresa J H Christianson; Bradley F Boeve; Eric G Tangalos; Robert J Ivnik; Ronald C Petersen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

Review 4.  Healthy brain aging: role of cognitive reserve, cognitive stimulation, and cognitive exercises.

Authors:  Asenath La Rue
Journal:  Clin Geriatr Med       Date:  2010-02       Impact factor: 3.076

5.  Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.

Authors:  Nicolaas I Bohnen; Roger L Albin; Martijn L T M Müller; Myria Petrou; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Kirk A Frey
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

6.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

7.  Bilateral simultaneous assessment of cerebral flow velocity during mental activity.

Authors:  M Silvestrini; L M Cupini; M Matteis; E Troisi; C Caltagirone
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

8.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

Review 9.  Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review.

Authors:  Thierry Paillard; Yves Rolland; Philipe de Souto Barreto
Journal:  J Clin Neurol       Date:  2015-07       Impact factor: 3.077

10.  Making sense of Cronbach's alpha.

Authors:  Mohsen Tavakol; Reg Dennick
Journal:  Int J Med Educ       Date:  2011-06-27
View more
  2 in total

Review 1.  Association of Hearing Loss with Physical, Social, and Mental Activity Engagement.

Authors:  Adele M Goman; Tess Gao; Joshua Betz; Nicholas S Reed; Jennifer A Deal; Frank R Lin
Journal:  Semin Hear       Date:  2021-04-15

Review 2.  Cognitive Interventions in Parkinson's Disease: Where We Want to Go within 20 Years.

Authors:  Elke Kalbe; Dag Aarsland; Ann-Kristin Folkerts
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.